Free Trial

Lipocine (LPCN) News Today

$5.21
+0.01 (+0.19%)
(As of 09:27 AM ET)
7 Penny Biotech Stocks to Triple Your Investment
LPCN Stock Earnings: Lipocine Beats EPS for Q4 2023
Lipocine GAAP EPS of -$3.14
Lipocine to Present at 36th Annual Roth Conference
Lipocine Signs TLANDO Franchise License Deal With Verity Pharma
Lipocine to Present at Biotech Showcase 2024
Lipocine files for $150M mixed shelf
Lipocine Inc LPCN
Get Lipocine News Delivered to You Automatically

Sign up to receive the latest news and ratings for LPCN and its competitors with MarketBeat's FREE daily newsletter.

Next opportunity for crypto millions (Ad)

October isn't just another month in crypto. It's the launchpad for what could be the most explosive bull run in history. And I've found the rocket fuel… One coin is quietly positioning itself to outperform the entire market. The signs are everywhere…

Go here to discover the coin that could define this historic bull run with gains kicking off this mo

LPCN Media Mentions By Week

LPCN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LPCN
News Sentiment

0.55

0.71

Average
Medical
News Sentiment

LPCN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LPCN Articles
This Week

7

1

LPCN Articles
Average Week

Get Lipocine News Delivered to You Automatically

Sign up to receive the latest news and ratings for LPCN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LPCN) was last updated on 10/11/2024 by MarketBeat.com Staff
From Our Partners